老虎证券

BRIEF-Chemours Outlook FY Adjusted EBITDA Between $825 Million And $975 Million

Reuters
02-18
BRIEF-Chemours Outlook FY Adjusted EBITDA Between $825 Million And $975 Million

Feb 18 (Reuters) - Chemours Co CC.N:

  • CHEMOURS: OUTLOOK FY ADJUSTED EBITDA BETWEEN $825 MILLION AND $975 MILLION

  • CHEMOURS: OUTLOOK FY CAPITAL EXPENDITURES BETWEEN $250 MILLION TO $300 MILLION

  • CHEMOURS: OUTLOOK Q1 CONSOLIDATED NET SALES TO BE FLAT TO SLIGHTLY DOWN SEQUENTIALLY

  • CHEMOURS: QTRLY NET SALES OF $1.4 BILLION

  • CHEMOURS: QTRLY ADJUSTED EPS $0.11

  • CHEMOURS: IN 2024, FULLY REMEDIATED ALL FOUR MATERIAL WEAKNESSES IN INTERNAL CONTROL PREVIOUSLY IDENTIFIED IN THE 2023 FORM 10-K

  • Q4 EARNINGS PER SHARE VIEW $0.12, REVENUE VIEW $1.36 BILLION -- LSEG IBES DATA

  • Q1 REVENUE VIEW $1.41 BILLION -- LSEG IBES DATA

Source text: ID:nBwb2qq3ha

Further company coverage: CC.N

((Reuters.Briefs@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10